First AD

Second AD

Novel Targeted Therapies for LCNEC of the Lung

How can novel targeted therapies, such as T-cell engagers, potentially improve outcomes for patients with lung LCNEC and other NECs?

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)  

Panelists discuss how novel targeted therapies, such as T-cell engagers, could improve outcomes for patients with lung large cell neuroendocrine carcinoma (LCNEC) and other neuroendocrine cancers (NECs).

Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

An Overview of the Molecular Characterization of Lung LCNEC

The Pathological Diagnosis of Lung LCNEC 

Biomarker Testing Strategies for Lung LCNEC 

Biopsy Best Practices: Diagnosing Lung LCNEC

Lung LCNEC Diagnostic Challenges

A Multidisciplinary Approach to Managing Lung LCNEC

Lung LCNEC Disease Histology and Prognosis

The Role of DLL3 in LCNEC of the Lung

Insights on the LANCE Pilot Study on Lung LCNEC

Overview of Studies of BI 764532 for Lung LCNEC

Insights Into Ongoing Investigational Studies in Lung LCNEC

Potential Next-Generation Therapies for Lung LCNEC